Durable remission with rituximab in a patient with an unusual variant of <scp>C</scp>astleman's disease with myelofibrosis—<scp>TAFRO</scp> syndrome

Preetesh Jain

Department of Leukemia The University of Texas, M.D. Anderson Cancer Center Houston Texas
Srdan Verstovsek

Department of Leukemia The University of Texas, M.D. Anderson Cancer Center Houston Texas
Sanam Loghavi

Departments of Hematopathology, The University of Texas, M.D. Anderson Cancer Center Houston Texas
Jeffrey L. Jorgensen

Departments of Hematopathology, The University of Texas, M.D. Anderson Cancer Center Houston Texas
Keyur P. Patel

Departments of Hematopathology, The University of Texas, M.D. Anderson Cancer Center Houston Texas
Zeev Estrov

Department of Leukemia The University of Texas, M.D. Anderson Cancer Center Houston Texas
Luis Fayad

Lymphoma and Myeloma The University of Texas, M.D. Anderson Cancer Center Houston Texas
Naveen Pemmaraju

Department of Leukemia The University of Texas, M.D. Anderson Cancer Center Houston Texas